W
e previously showed that immune responses to brain antigens, particularly myelin basic protein, are associated with worse outcome after experimental stroke. 1 The spleen, the largest repository of lymphocytes within the body, undergoes profound atrophy after stroke. 2 There is a simultaneous increase in the number of mononuclear cells (lymphocytes and monocytes) within brain, with the implication being the spleen is the source of these cells. 3 Many studies show that splenectomy before or immediately after stroke improves outcome in rats, [4] [5] [6] [7] and splenectomy before hypoxic-ischemic injury was also found to be beneficial. 8 In mice, splenectomy 2 weeks before middle cerebral artery occlusion (MCAO) improved outcome in males but not in females, 9 whereas splenectomy at the time of MCAO was of no benefit. 10 We hypothesized that splenectomy immediately before MCAO would decrease mononuclear cell infiltration into the brain and attenuate immune responses to brain antigens, thereby improving outcome.
Methods

Animals
Male Lewis rats (275-350 g) were purchased from Harlan-US. All experiments were approved by the University of Washington Institutional Animal Care and Use Committee. Animals were randomly assigned to splenectomy or sham splenectomy; outcomes were assessed by individuals masked to treatment status. Sample size calculations were based on extant literature about splenectomy and stroke outcomes.
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Splenectomy
Anesthesia was induced with 5% and maintained with 1.5% isoflurane. The splenic artery, veins, and nerves were ligated, and the spleen removed through a small lateral peritoneal incision. For sham splenectomy, the spleen was identified but not removed.
Middle Cerebral Artery Occlusion
MCAO was performed immediately after splenectomy or sham splenectomy. A midline neck incision was made, and the right common and internal carotid arteries ligated. A monofilament suture (Doccol 4.0) was inserted into the common carotid and advanced into the internal carotid artery to block the origin of the middle cerebral artery. Animals were maintained at normothermia during surgery and reperfused 2 hours after MCAO. Rectal temperatures and body weight were assessed at set times. Animals were euthanized at 72 hours or 672 hours after surgery.
Behavioral Outcomes
Stroke severity was determined using a modified Bederson scale score. 11 Additional tests included the rotarod, foot fault, and the alternating T-maze. Animals were trained on the rotarod before MCAO; the ability to stay on the rotarod for 100-second intervals was tested. Performance on the foot fault test was expressed as the percentage of foot faults per total steps taken, and the percentage of appropriately alternating choices during 25 trials in a T-maze was calculated before and at 1 month after MCAO.
Background and Purpose-Immune responses to brain antigens after stroke contribute to poor outcome. We hypothesized that splenectomy would lessen the development of such responses and improve outcome. Methods-Male Lewis rats (275-350 g) underwent 2-hour middle cerebral artery occlusion immediately after splenectomy or sham splenectomy. Animals were survived to 4 weeks (672 hrs), and immune responses to myelin basic protein determined at euthanasia. Infarct volume was determined in a subset of animals euthanized at 72 hours. Behavioral outcomes were assessed to 672 hours. Results-Splenectomy was associated with worse neurological scores early after stroke, but infarct size at 72 hours was similar in both groups. Behavioral outcomes and immune responses to myelin basic protein were also similar among splenectomized and sham-operated animals 672 hours after middle cerebral artery occlusion. Conclusions-Splenectomy did not alter the immune responses to brain antigens or improve outcome after stroke.
Differences between this study and other studies of splenectomy and stroke are examined. 
ELISPOT Assays
Lymphocytes were isolated from the brain by separating the hemispheres and homogenizing the tissue through a 70-µm screen. The homogenate was spun over a Ficoll-Paque gradient to separate the lymphocytes from brain tissue. Lymphocytes (1×10 5 cells/well) were cultured in media alone or media supplemented with antigen or the mitogen concanavalin A (Sigma) for 48 hours in 96-well plates (Multiscreen-IP; Millipore). ELISPOT assays were used to detect rat myelin basic protein (NeoBioSci) and ovalbumin (Sigma)-specific secretion of interferon-γ, interleukin-17, and transforming growth factor-β1. Antigens were used at a concentration of 50 μg/mL and concanavalin A at 5 µg/mL. Responses were assessed in triplicate.
Plates were developed using standard protocols (R&D Systems). Spots were counted with the aid of a semiautomated system (AID iSPOT) and expressed as the ratio of the relative increase in antigen-specific interferon-γ-secreting cells to that of transforming growth factor-β1-secreting cells (Th1 response) or as the ratio of the relative increase in antigen-specific interleukin-17-secreting cells to that of transforming growth factor-β1-secreting cells (Th17 response).
Statistics
Parametric data are displayed as mean±SD and compared using the t test. Nonparametric data are displayed as median (interquartile range) and compared using the Mann-Whitney U test. Categorical data are compared using the χ 2 test. Significance was set at P<0.05.
Results
Mortality was similar in animals undergoing splenectomy and sham splenectomy. The increase in body temperature after MCAO was attenuated in animals undergoing splenectomy ( Figure 1A) ; changes in body weight were similar in both groups ( Figure 1B) . Infarct volume at 72 hours was similar in animals undergoing splenectomy and sham splenectomy (230±136 versus 225±221 cc). Neurological scores were higher early after MCAO in splenectomized animals ( Figure 2A ). Performance on the foot fault test, rotarod, and alternating T-maze was similar in both groups ( Figure 2B through 2D ). There were no differences in the numbers of mononuclear cells isolated from the brains of animals undergoing splenectomy and sham splenectomy (15.4±4.3×10 6 versus 12.2±3.6×10 6 in the infarcted hemisphere and 11.5±3.1×10 6 versus 8.9±3.9×10 6 in the noninfarcted hemisphere). Furthermore, there were no differences in cellular immune responses (data not shown).
Discussion
We did not find a beneficial effect of splenectomy on either early or late outcomes after stroke. Our study differs from previous studies in several ways. Ours is the only study done in Lewis rats, which are more prone to immune-mediated diseases than Sprague-Dawley rats. 12 We performed splenectomy at the time of stroke as opposed to 2 weeks before, as in most previous studies. [4] [5] [6] The duration of follow-up was limited in previous studies, and few of these studies evaluated behavioral outcomes. [4] [5] [6] [7] Table outlines the characteristics of studies evaluating the effect of splenectomy on stroke outcome.
There are no data comparing strain-related differences in the immune response after stroke, but such differences could impact the effect of splenectomy on outcome. Strains prone to immune-mediated diseases should benefit more from splenectomy if inflammation worsens stroke outcome. It is, thus, surprising that no improvement was seen in Lewis rats, yet strains resistant to immunologic diseases (ie, SpragueDawley) benefitted from splenectomy. In a study done in C57BL/6 mice, splenectomy immediately before MCAO did not improve outcome. 10 In most positive studies, splenectomy was performed 2 weeks before MCAO, a time frame in which multiple systemic changes may occur. Furthermore, most positive studies induced permanent ischemia, [4] [5] [6] 9 whereas those showing no benefit induced transient ischemia. 10 If splenocytes contribute to poor stroke outcome, the beneficial effect should be more pronounced in models that establish reperfusion.
After stroke, the spleen atrophies 2 and the number of circulating lymphocytes decreases by 50%. 13 We previously found that the number of splenocytes decreases by ≈103×10
6
, and the number of mononuclear cells in brain increases by 0.4×10 6 at 72 hours after MCAO, 1 suggesting that most splenocytes lost from the spleen do not migrate to brain. Given the lymphopenia early after stroke, these lost splenocytes are not entering the circulation. Furthermore, we found that at 4 weeks after MCAO, animals undergoing splenectomy had just as many mononuclear cells in the brain as those with intact spleens.
We hypothesized that splenectomy would decrease autoimmune responses to brain after stroke but found that Th1 and Th17 responses to myelin basic protein were similar in animals undergoing splenectomy and sham splenectomy. In summary, 
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splenectomy at the time of MCAO did not decrease infarct volume, improve neurological outcome, or affect the immune responses to brain antigens. Additional studies are needed to explore the contribution of the spleen to ischemic brain injury.
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